Skip to main content

Advertisement

SpringerLink
Log in

Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period

  • Original Article
  • Published:
Modern Rheumatology

Abstract

The aim of this study was to investigate the types and prevalence of disease-specific antinuclear antibodies (ANAs) and their relationship to rheumatic diseases in the general Japanese population. An immunofluorescence (IF) method was used for the first screening of ANA levels in serum samples obtained from 2181 residents of a small Japanese town. Individuals positive for IF-ANA were then further tested for disease-specific ANAs using eight enzyme immunoassays. Physical status and the presence of illness were determined by means of questionnaires and medical examinations. Based on the result of the IF-ANA assay, the rates of positive samples at 1:40 and 1:160 dilutions were 26.0 and 9.5%, respectively, with females have significantly higher positivity rates than males (P < 0.0001). Among 566 IF-ANA-positive individuals, 100 individuals were found to have 114 disease-specific ANAs. Anti-SSA/Ro, anti-centromere, and anti-U1RNP antibodies were detected in 58, 30, and 11 individuals, respectively, but anti-Sm, anti-Scl-70, and anti-Jo-1 antibodies were undetectable. Questionnaires and medical examinations revealed that among 60 disease-specific ANA-positive individuals that were available for testing, six had Sjögren’s syndrome (SS), five were suspected of having SS, and five had rheumatoid arthritis. Surprisingly, 34 (57%) of the disease-specific ANA-positive individuals were clinically healthy. Anti-SSA/Ro, anti-centromere, and anti-U1RNP antibodies were quite frequent among clinically healthy Japanese subjects, although anti-Sm, anti-Scl-70, and anti-Jo-1 antibodies were not. Of the 60 individuals who tested positive for disease-specific ANAs, 30% (18/60) actually manifested systemic rheumatic diseases, while 50% showed no detectable signs or symptoms of rheumatic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989;44:93–151.

    PubMed  CAS  Google Scholar 

  2. Fujimoto M, Shimozuma M, Yazawa N, Kubo M, Ihn H, Sato S, et al. Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis. Ann Rheum Dis. 1997;56:667–70.

    PubMed  CAS  Google Scholar 

  3. Cleymaet JE, Nakamura RM. Indirect immunofluorescent antinuclear antibody tests: comparison of sensitivity and specificity of different substrates. Am J Clin Pathol. 1972;58:388–93.

    PubMed  CAS  Google Scholar 

  4. Kozin F, Fowler M, Koethe SM. A comparison of the sensitivities and specificities of different substrates for the fluorescent antinuclear antibody test. Am J Clin Pathol. 1980;74:785–90.

    PubMed  CAS  Google Scholar 

  5. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum. 1997; 40:1601–11.

    Article  PubMed  CAS  Google Scholar 

  6. Hayashi N, Kawamoto T, Mukai M, Morinobu A, Koshiba M, Kondo S, et al. Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. Clin Chem. 2001;47:1649–59.

    PubMed  CAS  Google Scholar 

  7. von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 1995;24:323–58.

    Article  Google Scholar 

  8. de Vlam K, De Keyser F, Verbruggen G, Vandenbossche M, Vanneuville B, D’Haese D, et al. Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol. 1993;11:393–7.

    PubMed  Google Scholar 

  9. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol. 1987;69:557–65.

    PubMed  CAS  Google Scholar 

  10. Azizah MR, Azila MN, Zulkifli MN, Norita TY. The prevalence of antinuclear, anti-dsDNA, anti-Sm and anti-RNP antibodies in a group of healthy blood donors. Asian Pac J Allergy Immunol. 1996;14:125–8.

    PubMed  CAS  Google Scholar 

  11. Juby AG, Davis P, McElhaney JE, Gravenstein S. Prevalence of selected autoantibodies in different elderly subpopulations. Br J Rheumatol. 1994;33:1121–4.

    Article  PubMed  CAS  Google Scholar 

  12. Ruffatti A, Calligaro A, Del Ross T, Bertoli MT, Doria A, Rossi L, et al. Anti-double-stranded DNA antibodies in the healthy elderly: prevalence and characteristics. J Clin Immunol. 1990;10:300–3.

    Article  PubMed  CAS  Google Scholar 

  13. Murakami A, Kojima K, Ohya K, Imamura K, Takasaki Y. A new conformational epitope generated by the binding of recombinant 70-kd protein and U1 RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease. Arthritis Rheum. 2002;46:3273–82.

    Article  PubMed  CAS  Google Scholar 

  14. Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjogren’s syndrome. J Clin Invest. 1975;55:1067–73.

    Article  PubMed  CAS  Google Scholar 

  15. Wold RT, Young FE, Tan EM, Farr RS. Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science. 1968;161:806–7.

    Article  PubMed  CAS  Google Scholar 

  16. Hansen KE, Arnason J, Bridges AJ. Autoantibodies and common viral illnesses. Semin Arthritis Rheum. 1998;27:263–71.

    Article  PubMed  CAS  Google Scholar 

  17. Muller S, Boire G, Ossondo M, Ricchiuti V, Smadja D, Vernant JC, et al. IgG autoantibody response in HTLV-I-infected patients. Clin Immunol Immunopathol. 1995;77:282–90.

    Article  PubMed  CAS  Google Scholar 

  18. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjogren’s syndrome. Results of a prospective concerted action supported by the European community. Arthritis Rheum. 1993;36:340–7.

    Article  PubMed  CAS  Google Scholar 

  19. Conrad K, Mehlhorn J. Diagnostic and prognostic relevance of autoantibodies in uranium miners. Int Arch Allergy Immunol. 2000;123:77–91.

    Article  PubMed  CAS  Google Scholar 

  20. Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis. 2001;60:1131–6.

    Article  PubMed  CAS  Google Scholar 

  21. Ruffatti A, Artifoni L, Glorioso S, Calligaro A, Doria A, Gambari P, et al. Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients. J Rheumatol. 1985;12:940–3.

    PubMed  CAS  Google Scholar 

  22. Soma Y, Takehara K, Ishibashi Y. Clinical distribution of anticentromere antibody in Japanese patients. Dermatologica. 1989;178:16–9.

    Article  PubMed  CAS  Google Scholar 

  23. Spiewak R, Stojek N. Antinuclear antibodies among eastern-Polish rural inhabitants. Ann Agric Environ Med. 2003;10:207–9.

    PubMed  Google Scholar 

  24. Keech CL, McCluskey J, Gordon TP. Transfection and overexpression of the human 60-kDa Ro/SS-A autoantigen in HEp-2 cells. Clin Immunol Immunopathol. 1994;73:146–51.

    Article  PubMed  CAS  Google Scholar 

  25. Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum. 1999;42:455–64.

    Article  PubMed  CAS  Google Scholar 

  26. Tan EM, Smolen JS, McDougal JS, Fritzler MJ, Gordon T, Hardin JA, et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content. J Rheumatol. 2002;29:68–74.

    PubMed  CAS  Google Scholar 

  27. Adebajo AO, Charles P, Maini RN, Hazleman BL. Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population. Clin Exp Immunol 1993;92:73–6.

    Article  PubMed  CAS  Google Scholar 

  28. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995;21:613–9.

    PubMed  CAS  Google Scholar 

  29. Li L, Chen M, Huang DY, Nishioka M. Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I. J Gastroenterol Hepatol. 2001;16:245–7.

    Article  Google Scholar 

  30. Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol. 1983;1:195–205.

    PubMed  CAS  Google Scholar 

  31. Bernstein RM, Callender ME, Neuberger JM, Hughes GR, Williams R. Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis. 1982;41:612–4.

    Article  PubMed  CAS  Google Scholar 

  32. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349:1526–33.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Mr. Tsutomu Iwanami and Ms. Sanae Ohgaki (Health Center of Y Town) for their excellent technical support of the health examinations. We also thank Mr. Hiroshi Suno, Mr. Jiro Arai, and Mr. Yasushi Ishihara (Medical & Biological Laboratories), Mr. Kazuo Ohkubo (Mitsubishi Kagaku Iatron), Mr. Kotaro Banno (Dade Behring), Mr. Takahiko Tsuchida (Abbott Japan), and Mr. Tatsuya Nomura (Fujirebio) for providing reagent kits and technical advice. This research was supported in part by a Grant-in-Aid for Scientific Research (12922105) from the Japan Society for the Promotion of Science and by research grants (044-0211-1558) from the Ministry of Health, Labour and Welfare of Japan.

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan

    Nobuhide Hayashi, Seiji Kawano & Shunichi Kumagai

  2. Department of Clinical Laboratory Medicine, Hyogo College of Medicine, Hyogo, Japan

    Masahiro Koshiba

  3. Division of Evidence-based Laboratory Medicine (Sysmex), Department of Biomedical Informatics, Kobe University Graduate School of Medicine, Kobe, Japan

    Kunihiro Nishimura, Daisuke Sugiyama & Shunichi Kumagai

  4. Department of Rheumatology, Hyogo Rehabilitation Center, Kobe, Japan

    Tomoko Nakamura

  5. Division of Clinical Pathology and Immunology, Department of Biomedical Informatics, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan

    Sahoko Morinobu & Shunichi Kumagai

Authors
  1. Nobuhide Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masahiro Koshiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kunihiro Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daisuke Sugiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomoko Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sahoko Morinobu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Seiji Kawano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shunichi Kumagai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shunichi Kumagai.

About this article

Cite this article

Hayashi, N., Koshiba, M., Nishimura, K. et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 18, 153–160 (2008). https://doi.org/10.1007/s10165-008-0028-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-008-0028-1

Keywords

Search

Navigation